EICHORCondition: Non-Small Cell Lung Cancer · Sponsor: Achieve Life Sciences
The primary objective of the study is to compare overall survival of participants randomized to receiving custirsen in combination with docetaxel with participants randomized to receive docetaxel alone.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University Cancer Institute | Boynton Beach, Florida, United States | — |
| Florida Hospital | Orlando, Florida, United States | — |
| University Cancer and Blood Center, LLC | Athens, Georgia, United States | — |
| Joliet Oncology-Hematology Associates Ltd. | Joliet, Illinois, United States | — |
| Kentucky Cancer Clinic | Hazard, Kentucky, United States | — |
| Missouri Baptist Cancer Center | St Louis, Missouri, United States | — |
| Novant Health | Winston-Salem, North Carolina, United States | — |
| Summa Health System | Akron, Ohio, United States | — |
| Aultman Hospital | Canton, Ohio, United States | — |
| Center for Biomedical Research LLC | Knoxville, Tennessee, United States | — |
| Sarah Cannon Cancer Center | Nashville, Tennessee, United States | — |
| Blood and Cancer Center of East Texas | Tyler, Texas, United States | — |
+ 66 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01630733